Fidelity Investments’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$140K Sell
8,195
-414,297
-98% -$7.08M ﹤0.01% 3465
2025
Q1
$27M Sell
422,492
-270,374
-39% -$17.3M ﹤0.01% 1585
2024
Q4
$84.2M Sell
692,866
-542,876
-44% -$66M 0.01% 1186
2024
Q3
$154M Sell
1,235,742
-624,803
-34% -$78M 0.01% 919
2024
Q2
$294M Buy
1,860,545
+511,975
+38% +$80.9M 0.02% 641
2024
Q1
$175M Sell
1,348,570
-158,494
-11% -$20.5M 0.01% 845
2023
Q4
$145M Sell
1,507,064
-404,189
-21% -$39M 0.01% 873
2023
Q3
$232M Buy
1,911,253
+107,425
+6% +$13M 0.02% 634
2023
Q2
$207M Sell
1,803,828
-840,828
-32% -$96.3M 0.02% 710
2023
Q1
$365M Sell
2,644,656
-71,415
-3% -$9.84M 0.03% 501
2022
Q4
$352M Buy
2,716,071
+166,243
+7% +$21.5M 0.04% 508
2022
Q3
$282M Buy
2,549,828
+882,992
+53% +$97.6M 0.03% 542
2022
Q2
$125M Buy
1,666,836
+116,900
+8% +$8.76M 0.01% 879
2022
Q1
$121M Sell
1,549,936
-1,347,437
-47% -$105M 0.01% 994
2021
Q4
$261M Sell
2,897,373
-1,254,075
-30% -$113M 0.02% 698
2021
Q3
$384M Sell
4,151,448
-275,750
-6% -$25.5M 0.03% 533
2021
Q2
$344M Sell
4,427,198
-2,455
-0.1% -$191K 0.03% 592
2021
Q1
$330M Sell
4,429,653
-1,604,736
-27% -$120M 0.03% 583
2020
Q4
$1.03B Sell
6,034,389
-309,307
-5% -$52.7M 0.09% 199
2020
Q3
$891M Sell
6,343,696
-1,481,158
-19% -$208M 0.09% 205
2020
Q2
$1.25B Buy
7,824,854
+410,060
+6% +$65.7M 0.14% 131
2020
Q1
$725M Sell
7,414,794
-762,451
-9% -$74.6M 0.1% 187
2019
Q4
$1.06B Buy
8,177,245
+115,148
+1% +$14.9M 0.12% 166
2019
Q3
$607M Sell
8,062,097
-1,136,074
-12% -$85.6M 0.07% 266
2019
Q2
$1.4B Sell
9,198,171
-1,758,425
-16% -$267M 0.16% 113
2019
Q1
$1.31B Buy
10,956,596
+391,419
+4% +$46.7M 0.16% 124
2018
Q4
$1.15B Buy
10,565,177
+677,947
+7% +$74M 0.16% 120
2018
Q3
$1.6B Buy
9,887,230
+137,351
+1% +$22.2M 0.18% 99
2018
Q2
$1.29B Buy
9,749,879
+82,453
+0.9% +$10.9M 0.15% 130
2018
Q1
$716M Buy
9,667,426
+4,181,409
+76% +$310M 0.09% 249
2017
Q4
$305M Buy
5,486,017
+3,467,485
+172% +$193M 0.04% 530
2017
Q3
$91.6M Buy
2,018,532
+930,535
+86% +$42.2M 0.01% 1011
2017
Q2
$36.7M Sell
1,087,997
-34,000
-3% -$1.15M ﹤0.01% 1429
2017
Q1
$33.2M Sell
1,121,997
-74,800
-6% -$2.21M ﹤0.01% 1490
2016
Q4
$32.8M Sell
1,196,797
-337,600
-22% -$9.26M ﹤0.01% 1486
2016
Q3
$94.2M Sell
1,534,397
-268,500
-15% -$16.5M 0.01% 1008
2016
Q2
$34.4M Hold
1,802,897
﹤0.01% 1434
2016
Q1
$35.2M Sell
1,802,897
-565,500
-24% -$11M ﹤0.01% 1400
2015
Q4
$91.4M Buy
2,368,397
+292,185
+14% +$11.3M 0.01% 1003
2015
Q3
$66.7M Hold
2,076,212
0.01% 1124
2015
Q2
$63.2M Buy
2,076,212
+818,779
+65% +$24.9M 0.01% 1237
2015
Q1
$16.7M Hold
1,257,433
﹤0.01% 1797
2014
Q4
$18.2M Hold
1,257,433
﹤0.01% 1774
2014
Q3
$26.5M Hold
1,257,433
﹤0.01% 1619
2014
Q2
$37.5M Buy
1,257,433
+177,500
+16% +$5.29M 0.01% 1480
2014
Q1
$26M Hold
1,079,933
﹤0.01% 1651
2013
Q4
$22M Sell
1,079,933
-220,229
-17% -$4.49M ﹤0.01% 1671
2013
Q3
$61.4M Buy
1,300,162
+442,900
+52% +$20.9M 0.01% 1182
2013
Q2
$32.6M Buy
+857,262
New +$32.6M 0.01% 1444